Cold Chain

Company’s 344,000 square-foot facility revolves around pharma and medical items

Ultra low-temperature freezers continue to change the game in cold chain

In deal to be finalized by October, purchases B Medical Systems for $423 million

Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity

With the use of mRNA vaccines on the rise, so is the need for dedicated freezing and storing solutions

Acquisition of healthcare logistics company to play a role in delivery of pharma and biologic treatments

Cold chain logistics deal expands business’ international reach

Partnership allows for distribution of packager’s temperature-controlled container

Will serve as a hub, as company aims for growth in the European region

Transaction totals about $3 billion

Deal expands CDMO’s presence in Europe

How can pharma manufacturers and distributors balance logistical demands and environmental impact?

Company anticipating to double global network size by end of the year

Graham Cromb, Vice President of Europe Operations at UPS Healthcare talks about how the COVID-19 pandemic fueled UPS’ expansion in Europe, and where the company is heading in the post-COVID landscape

Facility adds to company’s global network

Acquisition works toward addressing needs of regenerative medicine industry

North Carolina Collaboratory and SAS partnership using IoT analytics and sensor data from vaccine storage freezers to strengthen cold chain integrity and improve dosage delivery

Features growth of cold storage, visual inspections capacity

Reportedly provides 270 hours of independent runtime for temperature-sensitive pharma transportation

KTEvolution “can easily be carried by one or two people”

The pharma logistics peak season—and most of 2022—is going to be challenging for pharmaceutical shippers, forwarders and the air cargo industry. But making slight changes—such as choosing the right packaging—can make it easier.

Crēdo ProEnvision Software 2.0, company says, expected to improve the customer experience for cold chain clients

The UK‘s imminent CO2 shortage crisis is second time in less than a year that CO2 shortages have threatened critical cold chains. As the demand for COVID-19 vaccines, mRNA-based therapies and precision medicine treatments grows, organizations will have to rethink their ultra-low temperature (ULT) strategies to prevent these shortages from impacting the pharma cold chain, writes Shea Vincent.

A chat with Cardinal Health’s Joel Wayment, who dives into what can be done to help ensure that patients receive their necessary medications, no matter the conditions

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector